| Absorption |
| Blood-Brain Barrier | BBB+ | 0.5060 |
| Human Intestinal Absorption | HIA+ | 0.6114 |
| Caco-2 Permeability | Caco2- | 0.8877 |
| P-glycoprotein Substrate | Non-substrate | 0.6276 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9399 |
| Non-inhibitor | 0.9204 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9340 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6708 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8698 |
| CYP450 2D6 Substrate | Non-substrate | 0.8809 |
| CYP450 3A4 Substrate | Non-substrate | 0.7406 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8550 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9350 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9367 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9306 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8950 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9798 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9808 |
| Non-inhibitor | 0.9309 |
| AMES Toxicity | Non AMES toxic | 0.8459 |
| Carcinogens | Non-carcinogens | 0.7983 |
| Fish Toxicity | Low FHMT | 0.7383 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.9291 |
| Honey Bee Toxicity | High HBT | 0.6009 |
| Biodegradation | Ready biodegradable | 0.9277 |
| Acute Oral Toxicity | III | 0.3941 |
| Carcinogenicity (Three-class) | Non-required | 0.7552 |